Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel Kool

Showing results (281-290 of 318) with videos related to

Pageof 32
Sort By:
Cancer Research|November 3, 2017
PDX-MI: Minimal Information for Patient-Derived Tumor Xenograft ModelsTerrence F Meehan, Nathalie Conte, Theodore Goldstein, et al.
Acta Neuropathologica|August 21, 2021
PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrumKaram T Alhalabi, Damian Stichel, Philipp Sievers, et al.
Nature|January 31, 2012
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastomaJeremy Schwartzentruber, Andrey Korshunov, Xiao-Yang Liu, et al.
Neuro-Oncology|June 2, 2021
Therapeutic implications of improved molecular diagnostics for rare CNS embryonal tumor entities: results of an international, retrospective studyKatja von Hoff, Christine Haberler, Felix Schmitt-Hoffner, et al.
Acta Neuropathologica|July 19, 2018
Heterogeneity within the PF-EPN-B ependymoma subgroupFlorence M G Cavalli, Jens-Martin Hübner, Tanvi Sharma, et al.
Nature|April 17, 2020
Germline Elongator mutations in Sonic Hedgehog medulloblastomaSebastian M Waszak, Giles W Robinson, Brian L Gudenas, et al.
Nature|December 6, 2019
The molecular landscape of ETMR at diagnosis and relapseSander Lambo, Susanne N Gröbner, Tobias Rausch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2021
Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed MedulloblastomaRahul Kumar, Kyle S Smith, Maximilian Deng, et al.
Acta Neuropathologica Communications|December 26, 2014
WNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastomaNataliya Zhukova, Vijay Ramaswamy, Marc Remke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2013
Subgroup-specific prognostic implications of TP53 mutation in medulloblastomaNataliya Zhukova, Vijay Ramaswamy, Marc Remke, et al.
Pageof 32

Showing results (281-290 of 318) with videos related to

Sort By:
Pageof 32
Cancer Research|November 3, 2017
PDX-MI: Minimal Information for Patient-Derived Tumor Xenograft ModelsTerrence F Meehan, Nathalie Conte, Theodore Goldstein, et al.
Acta Neuropathologica|August 21, 2021
PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrumKaram T Alhalabi, Damian Stichel, Philipp Sievers, et al.
Nature|January 31, 2012
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastomaJeremy Schwartzentruber, Andrey Korshunov, Xiao-Yang Liu, et al.
Neuro-Oncology|June 2, 2021
Therapeutic implications of improved molecular diagnostics for rare CNS embryonal tumor entities: results of an international, retrospective studyKatja von Hoff, Christine Haberler, Felix Schmitt-Hoffner, et al.
Acta Neuropathologica|July 19, 2018
Heterogeneity within the PF-EPN-B ependymoma subgroupFlorence M G Cavalli, Jens-Martin Hübner, Tanvi Sharma, et al.
Nature|April 17, 2020
Germline Elongator mutations in Sonic Hedgehog medulloblastomaSebastian M Waszak, Giles W Robinson, Brian L Gudenas, et al.
Nature|December 6, 2019
The molecular landscape of ETMR at diagnosis and relapseSander Lambo, Susanne N Gröbner, Tobias Rausch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2021
Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed MedulloblastomaRahul Kumar, Kyle S Smith, Maximilian Deng, et al.
Acta Neuropathologica Communications|December 26, 2014
WNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastomaNataliya Zhukova, Vijay Ramaswamy, Marc Remke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2013
Subgroup-specific prognostic implications of TP53 mutation in medulloblastomaNataliya Zhukova, Vijay Ramaswamy, Marc Remke, et al.
Pageof 32